Mechanistic characterization and regulation of the non-redundant phu and has heme uptake systems of Pseudomonas aeruginosa
铜绿假单胞菌非冗余phu和血红素摄取系统的机制表征和调控
基本信息
- 批准号:10383767
- 负责人:
- 金额:$ 38.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffinityAllelesAnabolismAnti-Bacterial AgentsAntibioticsAssimilationsBiliverdineBiochemicalBiological MarkersChronicClinicalDataDevelopmentDrug resistanceFeedbackFutureGeneticGenetic TranscriptionGoalsGrowthHemeHemoglobinImmuneImmune responseIn VitroInfectionInnate Immune ResponseIronIsomerismIsotope LabelingIsotopesKnock-outLabelLaboratoriesLeadLung infectionsMembraneMessenger RNAMetabolismMethodsModelingMolecularMulti-Drug ResistanceMusMutationNosocomial InfectionsOperonPathogenesisPatientsPeptide HydrolasesPeriodicityPost-Transcriptional RegulationProteinsProteomicsPseudomonasPseudomonas aeruginosaRegulationRegulatory ElementRoleSiderophoresSignal TransductionSite-Directed MutagenesisSourceSpatial DistributionSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSubstrate SpecificitySystemTechniquesTestingTimeTranscriptional RegulationType III Secretion System PathwayVirulenceVirulence FactorsWorld Health Organizationacute infectionbacterial geneticsbasechronic infectioncystic fibrosis patientsdefined contributionexperimental studyextracellularin vivoinnovationinsightmass spectrometric imagingmultidrug-resistant Pseudomonas aeruginosamutantnew therapeutic targetnovelopportunistic pathogenpathogenpathogenic bacteriapromoterprotein expressionpulmonary function declinepyochelinpyoverdinreceptorresistant strainsensortraffickingtraittranscriptome sequencingtranscriptomicsuptake
项目摘要
Pathogenic bacteria require iron for their survival and virulence. The opportunistic pathogen Pseudomonas
aeruginosa has multiple mechanisms by which it can acquire iron, including ferric and ferrous iron uptake
systems. However, within the host P. aeruginosa can adapt to utilize heme via the heme assimilation (has) and
Pseudomonas heme utilization (phu) systems. We have recently shown the OM receptor PhuR has a unique
His-Tyr coordination, which is an emerging motif in high affinity heme acquisition systems. 13C-heme isotopic
labeling studies combined with bacterial genetics suggest the PhuR receptor is the high capacity uptake
receptor, with the HasR receptor acting primarily as a sensor and regulator of heme utilization. Furthermore,
we have shown the heme metabolite biliverdin IXβ is a feedback regulator of the heme sensing system (has),
as well as several virulence mechanisms including the pyochelin and Zn/Ni-pseudopaline uptake system, Type
III secretion systems (ExoS and ExoT), and extracellular proteases (LasB). The goal of the proposal is to
understand the regulation and molecular mechanism of heme acquisition in P. aeruginosa. Specifically, we will
elucidate the heme-dependent regulatory elements controlling expression of the has system through
transcriptional and translational fusion studies. Targeted transcriptional and post-transcriptional studies will be
complimented by global analysis through transcriptomic and and proteomic analyses. We will further define
the substrate specificity of the bis-His HasR and His-Tyr coordinated PhuR and their respective contributions to
heme acquisition and regulation. Contributions of the Has and Phu systems to heme acquisition and virulence
within the host will be tested in murine acute and chronic lung infection models. In addition, dual RNA-seq will
be performed to simultaneously determine the P. aeruginosa and murine host response to infection. MALDI-
MSI will be used in combination with quantitative LC-MS methods to determine the spatial distribution heme
metabolites (BVIX isomers) and host-pathogen biomarkers in PAO1 and heme utilization mutants. Completion
of the studies will provide a molecular basis for P. aeruginosa adaption to heme utilization in the context of the
host-pathogen interaction.
致病细菌需要铁才能生存和病毒。机会性病原体假单胞菌
铜绿菌具有多种机制,可以通过这些机制获取铁,包括铁和铁铁吸收
系统。但是,在宿主的铜绿假单胞菌中可以通过血红素同化(HAS)和
假单胞菌血红素利用率(PHU)系统。我们最近显示了OM接收器Phur具有独特的
HIS-TYR协调,这是高亲和力血红素获取系统中新兴的主题。 13C血红素同位素
与细菌遗传学结合的标记研究表明,Phur受体是高容量的吸收
受体,HOSR受体主要起作用是血红素利用的传感器和调节剂。此外,
我们已经表明,血红素代谢产物IXβ是血红素传感系统(HAS),)的反馈调节剂
以及几种病毒机制在内
III分泌系统(Exos和Exot)和细胞外蛋白酶(LASB)。该提议的目的是
了解铜绿假单胞菌中血红素获取的调节和分子机制。具体来说,我们会的
阐明控制Heme依赖性调节元件,以控制其通过
转录和翻译融合研究。针对性的转录和转录后研究将是
通过转录组和蛋白质组学分析的全球分析表示赞赏。我们将进一步定义
双HIS HASR的底物特异性和His-Tyr协调的Phur及其对各自的贡献
血红素的获取和调节。 HAS和PHU系统对血红素的贡献和病毒的贡献
在鼠急性和慢性肺部感染模型中将测试宿主内部。此外,双RNA-Seq将
进行同时确定铜绿假单胞菌和鼠宿主对感染的反应。马尔代
MSI将与定量LC-MS方法结合使用,以确定空间分布血红素
PAO1和血红素使用突变体中的代谢物(BVIX异构体)和宿主 - 病原生物标志物。完成
研究将为铜绿假单胞菌适应血红素利用的分子基础
宿主 - 病原体相互作用。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Repurposing Acitretin as an Antipseudomonal Agent Targeting the Pseudomonas aeruginosa Iron-Regulated Heme Oxygenase.
- DOI:10.1021/acs.biochem.0c00895
- 发表时间:2021-02
- 期刊:
- 影响因子:2.9
- 作者:Elizabeth Robinson;A. Wilks;F. Xue
- 通讯作者:Elizabeth Robinson;A. Wilks;F. Xue
Extracellular haem utilization by the opportunistic pathogen Pseudomonas aeruginosa and its role in virulence and pathogenesis.
- DOI:10.1016/bs.ampbs.2021.07.004
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Mouriño S;Wilks A
- 通讯作者:Wilks A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Angela Wilks其他文献
Angela Wilks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Angela Wilks', 18)}}的其他基金
2023 Cell Biology of Metals Gordon Research Conference and Gordon Research Seminar
2023金属细胞生物学戈登研究会议暨戈登研究研讨会
- 批准号:
10753741 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Pseudomonas aeruginosa heme sensing inhibitors targeting HasAp
针对 HasAp 的铜绿假单胞菌血红素传感抑制剂
- 批准号:
10231736 - 财政年份:2021
- 资助金额:
$ 38.33万 - 项目类别:
Pseudomonas aeruginosa heme sensing inhibitors targeting HasAp
针对 HasAp 的铜绿假单胞菌血红素传感抑制剂
- 批准号:
10331888 - 财政年份:2021
- 资助金额:
$ 38.33万 - 项目类别:
Mechanistic characterization and regulation of the non-redundant phu and has heme uptake systems of Pseudomonas aeruginosa
铜绿假单胞菌非冗余phu和血红素摄取系统的机制表征和调控
- 批准号:
9916715 - 财政年份:2018
- 资助金额:
$ 38.33万 - 项目类别:
Mechanistic characterization and regulation of the non-redundant phu and has heme uptake systems of Pseudomonas aeruginosa
铜绿假单胞菌非冗余phu和血红素摄取系统的机制表征和调控
- 批准号:
9592815 - 财政年份:2018
- 资助金额:
$ 38.33万 - 项目类别:
Heme utilization and homeostasis in Pseudomonas aeruginosa
铜绿假单胞菌的血红素利用和稳态
- 批准号:
9173014 - 财政年份:2012
- 资助金额:
$ 38.33万 - 项目类别:
Heme utilization and homeostasis in Pseudomonas aeruginosa
铜绿假单胞菌的血红素利用和稳态
- 批准号:
8774579 - 财政年份:2012
- 资助金额:
$ 38.33万 - 项目类别:
Heme utilization and homeostasis in Pseudomonas aeruginosa
铜绿假单胞菌的血红素利用和稳态
- 批准号:
8413570 - 财政年份:2012
- 资助金额:
$ 38.33万 - 项目类别:
Heme utilization and homeostasis in Pseudomonas aeruginosa
铜绿假单胞菌的血红素利用和稳态
- 批准号:
8584280 - 财政年份:2012
- 资助金额:
$ 38.33万 - 项目类别:
2010 Chemistry and Biology of Tetrapyrroles Gordon Research Conference
2010年四吡咯化学与生物学戈登研究会议
- 批准号:
7896921 - 财政年份:2010
- 资助金额:
$ 38.33万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Novel targeted therapy to reduce health disparities in pediatric leukemia
减少儿童白血病健康差异的新型靶向治疗
- 批准号:
10608229 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
The effects of APOE genotype in homeostatic microglial function in preclinical APOE mouse model
APOE基因型对临床前APOE小鼠模型稳态小胶质细胞功能的影响
- 批准号:
10828613 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
针对分子定义的难治性黑色素瘤子集的新型细胞治疗方法
- 批准号:
10780289 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别: